Literature DB >> 10320832

Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep.

C D McMahon1, D F Buxton, T H Elsasser, D R Gunter, L G Sanders, B P Steele, J L Sartin.   

Abstract

The objective of this study was to determine whether neuropeptide Y (NPY) and recombinant human interleukin-1 receptor antagonist (IL-1ra) would: first, increase food intake; secondly, decrease concentrations of GH; thirdly, reduce GHRH-induced release of GH; and fourthly, reduce changes to concentrations of IGF-I in plasma during experimental endotoxemia in sheep. Six treatments were given to six castrated male sheep in a 6x6 Latin square treatment order. Osmotic mini-pumps were implanted at 0 h and a jugular vein was cannulated. Each sheep was continuously infused with saline (0.9%) or lipopolysaccharide (LPS) (20 micrograms/kg per 24 h, s.c.) at 10 microliters/h for 72 h via the osmotic mini-pumps. Blood samples (3 ml) were collected at 15-min intervals from 24 to 33 h. At 26 h, one of three treatments (artificial cerebrospinal fluid, NPY or IL-1ra) was injected i.c.v. within 30 s (0.3 microgram/kg), then infused i.c.v. from 26 to 33 h (600 microliters/h) at 0.3 microgram/kg per h. GHRH was injected i.v. (0.075 microgram/kg) at 32 h after which blood samples were collected at 5, 10, 15, 30, 45 and 60 min. Feed intake was reduced up to 50% for 48 h in LPS-treated compared with non-LPS-treated sheep. NPY restored feed intake in LPS-treated sheep and induced hyperphagia in non-LPS-treated sheep from 24 to 48 h. In contrast, IL-1ra did not affect appetite. Injection of NPY increased concentrations of GH from 26 to 27 h, while IL-1ra had no effect. Infusion of NPY suppressed GHRH-induced release of GH. However, no treatment altered pulse secretion parameters of GH. Concentrations of IGF-I were 20% higher at 72 h in LPS-treated sheep given NPY than in sheep treated with LPS alone, and this may reflect increased appetite from 24 to 48 h. We concluded that reduced appetite during endotoxemia is due to down-regulation of an NPY-mediated mechanism. Furthermore, NPY stimulates release of GH in healthy sheep, does not reduce pulse secretion parameters of GH, but does suppress GHRH-induced release of GH in endotoxic sheep. Therefore, NPY may be an important neurotransmitter linking appetite with regulation of GH during endotoxemic and healthy states in sheep.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320832     DOI: 10.1677/joe.0.1610333

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  11 in total

1.  Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats.

Authors:  Melanie Felies; Stephan von Hörsten; Reinhard Pabst; Heike Nave
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

2.  Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge.

Authors:  Evelin Painsipp; Herbert Herzog; Peter Holzer
Journal:  J Psychopharmacol       Date:  2009-11-25       Impact factor: 4.153

3.  Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner.

Authors:  Martin E Edelsbrunner; Herbert Herzog; Peter Holzer
Journal:  Behav Brain Res       Date:  2009-05-03       Impact factor: 3.332

4.  Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice.

Authors:  Evelin Painsipp; Herbert Herzog; Peter Holzer
Journal:  Neuropharmacology       Date:  2008-05-10       Impact factor: 5.250

Review 5.  The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour.

Authors:  A Farzi; F Reichmann; P Holzer
Journal:  Acta Physiol (Oxf)       Date:  2015-01-09       Impact factor: 6.311

Review 6.  Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.

Authors:  Peter Holzer; Florian Reichmann; Aitak Farzi
Journal:  Neuropeptides       Date:  2012-09-11       Impact factor: 3.286

7.  Reproduction and beyond, kisspeptin in ruminants.

Authors:  Joseph A Daniel; Chad D Foradori; Brian K Whitlock; James L Sartin
Journal:  J Anim Sci Biotechnol       Date:  2015-05-28

8.  Prawn Shell Chitosan Exhibits Anti-Obesogenic Potential through Alterations to Appetite, Affecting Feeding Behaviour and Satiety Signals In Vivo.

Authors:  Áine M Egan; John V O'Doherty; Stafford Vigors; Torres Sweeney
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

Review 9.  Neuropeptides and the microbiota-gut-brain axis.

Authors:  Peter Holzer; Aitak Farzi
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

10.  Development of nonfibrotic left ventricular hypertrophy in an ANG II-induced chronic ovine hypertension model.

Authors:  Niklas Klatt; Katharina Scherschel; Claudia Schad; Denise Lau; Aline Reitmeier; Pawel Kuklik; Kai Muellerleile; Jin Yamamura; Tanja Zeller; Daniel Steven; Stephan Baldus; Benjamin Schäffer; Christiane Jungen; Christian Eickholt; Katharina Wassilew; Edzard Schwedhelm; Stephan Willems; Christian Meyer
Journal:  Physiol Rep       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.